Harvard Bioscience opened the stock market on Friday trending up more than 20% after its second-quarter earnings reflected an improved financial condition as the company focuses on improving its underlying performance.Â
Holliston lab equipment manufacturer Harvard Bioscience is expecting a weaker 2019 after a slow start to the year, which saw weaker demand from customers in Europe.
The Baker administration on Monday marked Earth Day by announcing $725,000 in grants to 27 communities, including Ayer, Bellingham, Franklin, Holliston and Northborough.
Revenue at Holliston medical device maker Harvard Bioscience climbed 20 percent last year, with profits rising to $7.4 million, the company said Thursday.
Holliston biotech Biostage is planning U.S. regulatory filings to begin marketing its esophagus-regenerating implants after a single-patient case in 2017 proved the company's technology works.